We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+11.52%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.77B
AUM Growth
+$189M
Cap. Flow
-$586M
Cap. Flow %
-15.53%
Top 10 Hldgs %
14.94%
Holding
381
New
11
Increased
47
Reduced
124
Closed
12

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$21.5M
2
VSTS icon
Vestis
VSTS
+$12.8M
3
VLTO icon
Veralto
VLTO
+$5.55M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.47M
5
FA icon
First Advantage
FA
+$5.45M

Sector Composition

Rank Sector Weight
1 Technology 20.04%
2 Industrials 15.65%
3 Financials 13.04%
4 Healthcare 11.52%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
126
Adobe
ADBE
$105B
$7.62M 0.2%
12,779
+25
+0.2% +$14.4K
MCD icon
127
McDonald's
MCD
$195B
$7.1M 0.19%
23,946
BAC.PRL icon
128
Bank of America Series L
BAC.PRL
$3.99B
$6.92M 0.18%
5,696
-977
-15% -$1.09M
PEP icon
129
PepsiCo
PEP
$190B
$6.92M 0.18%
40,739
-335
-0.8% -$55.6K
ZBRA icon
130
Zebra Technologies
ZBRA
$17.8B
$6.44M 0.17%
23,567
+1,076
+5% +$246K
SHW icon
131
Sherwin-Williams
SHW
$89.8B
$6.42M 0.17%
20,575
HRTX icon
132
Heron Therapeutics
HRTX
$92.9M
$6.2M 0.16%
3,646,103
-464,848
-11% -$512K
FA icon
133
First Advantage
FA
$4.12B
$6.18M 0.16%
+372,741
New +$5.45M
PACK icon
134
Ranpak Holdings
PACK
$473M
$5.88M 0.16%
1,009,935
-119,880
-11% -$506K
TRUP icon
135
Trupanion
TRUP
$1.18B
$5.75M 0.15%
188,540
-18,071
-9% -$479K
PWR icon
136
Quanta Services
PWR
$101B
$5.6M 0.15%
25,950
+498
+2% +$92K
TMO icon
137
Thermo Fisher Scientific
TMO
$220B
$5.55M 0.15%
10,465
+23
+0.2% +$11.1K
ORLY icon
138
O'Reilly Automotive
ORLY
$76.3B
$5.48M 0.15%
+86,520
New +$5.47M
NVDA icon
139
NVIDIA
NVDA
$5.42T
$5.09M 0.14%
102,770
+370
+0.4% +$17.1K
TXN icon
140
Texas Instruments
TXN
$261B
$4.57M 0.12%
26,811
FANG icon
141
Diamondback Energy
FANG
$52.7B
$4.5M 0.12%
28,991
+819
+3% +$128K
BRK.A icon
142
Berkshire Hathaway Class A
BRK.A
$1.12T
$4.34M 0.12%
8
XYZ
143
Block Inc
XYZ
$47.5B
$3.89M 0.1%
50,354
-1,750
-3% -$98.9K
NKE icon
144
Nike
NKE
$61.9B
$3.62M 0.1%
33,340
BURL icon
145
Burlington
BURL
$23.2B
$3.62M 0.1%
18,611
-314
-2% -$46.9K
PPLI
146
People Inc
PPLI
$3.1B
$3.42M 0.09%
79,652
-1,229
-2% -$48.1K
AMAT icon
147
Applied Materials
AMAT
$428B
$3.09M 0.08%
19,048
-12
-0.1% -$1.76K
DCI icon
148
Donaldson
DCI
$11.4B
$2.92M 0.08%
44,685
+847
+2% +$51.6K
INTU icon
149
Intuit
INTU
$89B
$2.89M 0.08%
4,628
-145
-3% -$80K
BOKF icon
150
BOK Financial
BOKF
$8.74B
$2.78M 0.07%
32,498
+2,933
+10% +$221K

Similar funds

Palisade Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Palisade Capital Management held 381 positions worth $3.77B, up 5.3% from $3.58B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Palisade Capital Management withdrew a net $586M in Q4 2023, closing 12 positions and reducing 124 holdings. Its most notable exit was Pediatrix Medical, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Palisade Capital Management opened a new position in iShares Russell 2000 ETF worth $24.1M.

  • Palisade Capital Management's largest Q4 2023 buy was iShares Russell 2000 ETF: 119,870 shares worth $24.1M.
  • Palisade Capital Management added most to Veralto in Q4 2023, an estimated $5.55M increase.
  • Palisade Capital Management's biggest Q4 2023 reduction was Applied Industrial Technologies, cutting an estimated $17.9M.
  • Palisade Capital Management fully exited Pediatrix Medical in Q4 2023, selling an estimated $10.5M.
  • Palisade Capital Management's ten largest holdings make up 15% of its $3.77B portfolio in Q4 2023.
  • Palisade Capital Management opened 11 new positions and closed 12 in Q4 2023.
  • Palisade Capital Management's portfolio value rose 5.3% quarter-over-quarter to $3.77B.

Based on Palisade Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.